Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus

被引:88
|
作者
Kreijtz, J. H. C. M. [1 ]
Bodewes, R. [1 ]
van den Brand, J. M. A. [1 ]
de Mutsert, G. [1 ]
Baas, C. [1 ]
van Amerongen, G. [1 ]
Fouchier, R. A. M. [1 ]
Osterhaus, A. D. M. E. [1 ]
Rimmelzwaan, G. F. [1 ]
机构
[1] Erasmus MC, Dept Virol, NL-3000 CA Rotterdam, Netherlands
关键词
Influenza virus; Heterosubtypic immunity; Cytotoxic T lymphocytes; CD8(+) T-CELLS; A VIRUS; HETEROSUBTYPIC IMMUNITY; HETEROTYPIC IMMUNITY; LYMPHOCYTES-T; M2; PROTEIN; HONG-KONG; H5N1; VACCINE; NUCLEOPROTEIN;
D O I
10.1016/j.vaccine.2009.05.079
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The transmission of highly pathogenic avian influenza (HPAI) A viruses of the H5N1 subtype from poultry to man and the high case fatality rate fuels the fear for a pandemic outbreak caused by these viruses. However, prior infections with seasonal influenza A/H1N1 and A/H3N2 viruses induce heterosubtypic immunity that could afford a certain degree of protection against infection with the HPAI A/H5N1 viruses, which are distantly related to the human influenza A viruses. To assess the protective efficacy of such heterosubtypic immunity mice were infected with human influenza virus A/Hong Kong/2/68 (H3N2) 4 weeks prior to a lethal infection with HPAI virus A/Indonesia/5/05 (H5N1). Prior infection with influenza virus A/Hong Kong/2/68 reduced clinical signs, body weight loss, mortality and virus replication in the lungs as compared to naive mice infected with HPAI virus A/Indonesia/5/05. Priming by infection with respiratory syncytial virus, a non-related virus did not have a beneficial effect on the outcome of A/H5N1 infections, indicating that adaptive immune responses were responsible for the protective effect. In mice primed by infection with influenza A/H3N2 virus cytotoxic T lymphocytes (CTL) specific for NP366-374 epitope ASNENMDAM and PA(224-232) SCLENFRAYV were observed. A small proportion of these CTL was cross-reactive with the peptide variant derived from the influenza A/H5N1 virus (ASNENMEVM and SSLENFRAYV respectively) and upon challenge infection with the influenza A/H5N1 virus cross-reactive CTL were selectively expanded. These CTL, in addition to those directed to conserved epitopes, shared by the influenza A/H3N2 and A/H5N1 viruses, most likely contributed to accelerated clearance of the influenza A/H5N1 virus infection. Although also other arms of the adaptive immune response may contribute to heterosubtypic immunity, the induction of virus-specific CTL may be an attractive target for development of broad protective vaccines. Furthermore the existence of pre-existing heterosubtypic immunity may dampen the impact a future influenza pandemic may have. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4983 / 4989
页数:7
相关论文
共 50 条
  • [41] Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes
    Wu, J.
    Zhang, F.
    Fang, F.
    Chang, H.
    Wang, F.
    Yang, Z.
    Sun, B.
    Chen, Z.
    VACCINE, 2010, 28 (15) : 2775 - 2781
  • [42] Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice
    Kreijtz, J. H. C. M.
    Bodewes, R.
    van Amerongen, G.
    Kuiken, T.
    Fouchier, R. A. M.
    Osterhaus, A. D. M. E.
    Rimmelzwaan, G. F.
    VACCINE, 2007, 25 (04) : 612 - 620
  • [43] Pathology of fatal human infection associated with avian influenza A H5N1 virus
    To, KF
    Chan, PKS
    Chan, KF
    Lee, WK
    Lam, WY
    Wong, KF
    Tang, NLS
    Tsang, DNC
    Sung, RYT
    Buckley, TA
    Tam, JS
    Cheng, AF
    JOURNAL OF MEDICAL VIROLOGY, 2001, 63 (03) : 242 - 246
  • [44] Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus
    Yang, Song
    Niu, Shumeng
    Guo, Zhihua
    Yuan, Ye
    Xue, Kun
    Liu, Sinan
    Jin, Hong
    VIROLOGY JOURNAL, 2013, 10
  • [45] Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus
    Song Yang
    Shumeng Niu
    Zhihua Guo
    Ye Yuan
    Kun Xue
    Sinan Liu
    Hong Jin
    Virology Journal, 10
  • [46] Environment: a potential source of animal and human infection with influenza A (H5N1) virus
    Horm, Srey V.
    Gutierrez, Ramona A.
    Sorn, San
    Buchy, Philippe
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2012, 6 (06) : 442 - 448
  • [47] Avian influenza and human H5N1 infection
    不详
    AUSTRALIAN VETERINARY JOURNAL, 2007, 85 (08) : N22 - N22
  • [48] Characterization of human influenza A (H5N1) virus infection in mice: neuro-, pneumo- and adipotropic infection
    Nishimura, H
    Itamura, S
    Iwasaki, T
    Kurata, T
    Tashiro, M
    JOURNAL OF GENERAL VIROLOGY, 2000, 81 : 2503 - 2510
  • [49] An Anti-H5N1 Influenza Virus FcDART Antibody Is a Highly Efficacious Therapeutic Agent and Prophylactic against H5N1 Influenza Virus Infection
    Zanin, Mark
    Keck, Zhen-Yong
    Rainey, G. Jonah
    Lam, Chia-Ying Kao
    Boon, Adrianus C. M.
    Rubrum, Adam
    Darnell, Daniel
    Wong, Sook-San
    Griffin, Yolanda
    Xia, Jinming
    Webster, Robert G.
    Webby, Richard
    Johnson, Syd
    Foung, Steven
    JOURNAL OF VIROLOGY, 2015, 89 (08) : 4549 - 4561
  • [50] Swine Influenza Virus A (H3N2) Infection in Human, Kansas, USA, 2009
    Cox, Chad M.
    Neises, Daniel
    Garten, Rebecca J.
    Bryant, Bill
    Hesse, Richard A.
    Anderson, Gary A.
    Trevino-Garrison, Ingrid
    Shu, Bo
    Lindstrom, Stephen
    Klimov, Alexander I.
    Finelli, Lyn
    EMERGING INFECTIOUS DISEASES, 2011, 17 (06) : 1143 - 1144